Compare ARW & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARW | ACHC |
|---|---|---|
| Founded | 1935 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | ARW | ACHC |
|---|---|---|
| Price | $113.44 | $14.20 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $102.00 | $24.38 |
| AVG Volume (30 Days) | 461.9K | ★ 3.4M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.79 | N/A |
| EPS | ★ 9.05 | 1.18 |
| Revenue | ★ $29,389,382,000.00 | $3,265,548,000.00 |
| Revenue This Year | $9.50 | $6.50 |
| Revenue Next Year | $4.23 | $4.38 |
| P/E Ratio | $12.55 | ★ $12.13 |
| Revenue Growth | 3.16 | ★ 4.58 |
| 52 Week Low | $86.50 | $12.63 |
| 52 Week High | $134.74 | $47.08 |
| Indicator | ARW | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 34.23 |
| Support Level | $110.82 | $13.60 |
| Resistance Level | $116.94 | $15.55 |
| Average True Range (ATR) | 2.38 | 0.95 |
| MACD | 1.16 | 0.08 |
| Stochastic Oscillator | 71.47 | 31.52 |
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.